I have only taken a couple of casual looks at ACL over the years, but I would rather buy and hold the out-and-out market leader with the track record to match for long periods.
Unless ACL is at a can’t-refuse kind of valuation, or SHL is egregiously valued (which it is not - kind of middle-of-the-road), sticking with the industry top dog is the way to go generally.
Ann: Half Yearly Report and Accounts, page-25
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$24.00 |
Change
-0.100(0.41%) |
Mkt cap ! $11.52B | |||
| Open | High | Low | Value | Volume |
| $23.87 | $24.01 | $23.77 | $48.41M | 2.011M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13000 | $23.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $24.00 | 4033 | 2 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$23.97 |
Change
-0.100 ( 0.81 %) |
||||
| Open | High | Low | Volume | ||
| $23.86 | $24.01 | $23.77 | 165480 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| SHL (ASX) Chart |